Review
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 259-272
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.259
Figure 3
Figure 3 Neoantigens created by oncogenesis are released and captured by dendritic cell for processing. Dendritic cells present the captured antigens on MHCI and MHCII molecules to T cells, resulting in the priming and activation of effector T-cell responses against the cancer-specific antigens. Finally, the activated effector T cells move toward and infiltrate to the tumor bed. MDSC: Myeloid-derived suppressor cells; ADCC: Antibody dependent cell mediated cytotoxicity; CTC: Circulating tumor cells; CTL: Cytotoxic T cell. Created with BioRender.com.